BioNTech extends COVID vaccine trials in China

Vaccine developer BioNTech has extended the second phase of clinical trials of its COVID-19 vaccine in China by six months until October, a registry of such trials showed. The vaccine is one of the most widely used in the world against COVID but has yet to be approved in China.

Share this post:

Share on facebook
Share on twitter
Share on pinterest
Share on whatsapp
Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner